Targeting the Epidermal Growth Factor Receptor in Colorectal Cancer: Advances and Controversies

Publisher： Karger

E-ISSN： 1423-0232|70|3|161-167

ISSN： 0030-2414

Source： Oncology, Vol.70, Iss.3, 2006-07, pp. : 161-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Epidermal Growth Factor Receptor in Colorectal Cancer: A Potential Therapeutic Role for Gastrin-Releasing Peptide Receptor Antagonists

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 160-161

Karger

Access to resources Recommend Favorite

Targeting the Human Epidermal Growth Factor Receptor 2 (HER2) in the Treatment of Breast Cancer: Recent Advances and Future Directions

By  

Reviews on Recent Clinical Trials, Vol. 2, Iss. 2, 2007-05 ,pp. : 111-116

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 33, Iss. 12, 2010-11 ,pp. : 704-709

Karger

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in Glioblastoma Treatment

By  

Current Signal Transduction Therapy, Vol. 7, Iss. 1, 2012-01 ,pp. : 3-13

Bentham Science Publishers

Access to resources Recommend Favorite

Relationships of Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor Expression to Clinical Outcomes in Patients with Colorectal Cancer

By  

Oncology, Vol. 76, Iss. 1, 2008-11 ,pp. : 42-48

Karger

Access to resources Recommend Favorite